TKG PACT Executive Briefings - 3-Minute Market Insights

Oct 16 2024 59 ep. 18 mins 9
TKG PACT Executive Briefings - 3-Minute Market Insights Podcast artwork

Welcome to the TKG PACT Executive Briefing, where in 3-minutes we highlight healthcare’s critical market access issues, policies, challenges, or trends. This resource offers condensed, 3-minute episodes of market insights. 
Our passion is on achieving the Quintuple Aim of enhancing patient experience, improving population health, reducing costs, improving the work life of health care providers and staff., and enhancing health equity in all aspects of care delivery. 
I’m Dr. Warren Smedley, thank you for joining us.

  Health & Fitness  Science
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


FACT Standards for Immune Effector Cells

Oct 16 2024 3 mins  
Send us a textThe topic for this week’s @The Kinetix Group PACT Executive Briefing is “The FACT Standards for Immune Effector Cells.” These accrediting standards were developed by the Foundation for the Accreditation of Cellular Therapy (FACT), using a consensus of experts to promote quality medical and laboratory practice across the field of immune effector cell therapy. Imm

Medication Adherence for Patients with Severe Mental Illness.

Oct 02 2024 3 mins  
Send us a textMedication Adherence for Patients with Severe Mental Illness.Adherence to prescribed medication regimens improves outcomes for patients with severe mental illness, such as schizophrenia, bipolar disorders, and major depressive disorder. Psychiatric disorders are a significant public health problem: schizophrenia affects about 23 million people worldwide, bipolar disor

CRISPR Gene-Editing Therapy

Sep 17 2024 3 mins  
Send us a textIntroduction to Gene-Editing Therapy: CRISPRCRISPR is a relatively new medical advancement that was inspired by the natural defense mechanism found in some microbes, such as bacteria. To protect themselves against invaders like viruses, these microbes capture snippets of the intruder’s DNA and store them away as segments called CRISPRs, or Clustered Regularly Inters

Introduction to Targeted Therapies: CAR T-cell Therapy

Sep 03 2024 3 mins  
Send us a textIntroduction to Targeted Therapies: CAR T-cell Therapy T-cell Transfer Therapy is a special type of immunotherapy that takes a person’s own T-cells (a type of immune cell), adds specific antigens to the T-cells that can identify the cancer cells, and puts them back into the person’s body. Cancer cells express unique antigens (signaling proteins). T-cells are progr

Provider Insights on the Impact of 340B Pricing

Aug 20 2024 3 mins  
Send us a textProvider Insights on the Impact of 340B Pricing.We frequently get asked for insights on how the 340B Drug Pricing Program may... or may not... be impacting the prescribing choices of participating covered entities. The Health Resources and Services Administration (HRSA) administers this federal program which is intended to help safety-net providers carry out their mis

The Federal NOPAIN Act

Aug 06 2024 3 mins  
Send us a textToday’s topic is the The Federal NOPAIN Act.The Federal “Non-Opioids Prevent Addiction In the Nation Act” (or, the “NOPAIN Act”), Senate bill S.586, was signed into law in December 2022. It takes effect this coming January as part of the Centers for Medicare and Medicaid Services 2025 OPPS proposed rule. The NOPAIN Act directs CMS to reimburse hospital and s

High Value Pharmacy Enterprise Framework

Jul 23 2024 4 mins  
Send us a textThe High-Value Pharmacy Enterprise Framework.The High-Value Pharmacy Enterprise Framework is a collection of evidence-based and expert recommended best practices designed to enhance health system pharmacy operations by ensuring safe, effective, and patient-centered medication management throughout the health-system pharmacy enterprise. It is gaining in popularity due

Introduction to Targeted Therapies: Monoclonal Antibodies

Jul 16 2024 3 mins  
Send us a textIntroduction to Targeted Therapies: Monoclonal AntibodiesTargeted Therapy is the foundation of Precision Medicine. Targeted therapy is a type of personalized treatment that targets specific proteins that control how cells grow, divide, and spread. Antibodies are produced naturally by our body and help the immune system recognize cells that cause disease, such as bacte

Pharmacist Collaborative Practice Agreements (CPAs)

Jun 25 2024 3 mins  
Send us a textAll 50 states now allow pharmacists and physicians to enter into Collaborative Practice Agreements (CPAs) in which one or more pharmacists establish a formal relationship with a prescriber, in which the prescriber can delegate specific tasks to a pharmacist under negotiated conditions, which would not otherwise be permitted under the pharmacist’s normal scope of pra

Understanding the “bagging” of Patient Medications

Jun 18 2024 3 mins  
Send us a textWhen a physician prescribes an expensive specialty medication for a patient, the traditional distribution process was for the provider to purchase the medication, administer it to the patient, and then bill the insurance company for the drug. This “buy-and-bill” process has been utilized for many years. In recent years, and to help control costs, third-party payer